Zimmer Biomet (ZBH) insider buying
20 open-market purchases of ZBH by Zimmer Biomet's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings.
The most recent: Ro Khanna bought — on February 17, 2026.
The biggest buyer over the period is Ro Khanna: 20 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 10 | $0 |
| 2025 | 10 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Ro Khanna | 20 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Feb 17, 2026 | Ro Khanna |
0 | $97.21 | — | — |
| Feb 17, 2026 | Ro Khanna |
0 | $97.21 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $85.93 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $85.93 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $86.55 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $86.55 | — | — |
| Jan 14, 2026 | Ro Khanna |
0 | $89.20 | — | — |
| Jan 14, 2026 | Ro Khanna |
0 | $89.20 | — | — |
| Jan 13, 2026 | Ro Khanna |
0 | $88.45 | — | — |
| Jan 13, 2026 | Ro Khanna |
0 | $88.45 | — | — |
| Nov 6, 2025 | Ro Khanna |
0 | $88.27 | — | — |
| Nov 6, 2025 | Ro Khanna |
0 | $88.27 | — | — |
| Nov 3, 2025 | Ro Khanna |
0 | $99.86 | — | — |
| Nov 3, 2025 | Ro Khanna |
0 | $99.86 | — | — |
| Aug 4, 2025 | Ro Khanna |
0 | $92.48 | — | — |
| Aug 4, 2025 | Ro Khanna |
0 | $92.48 | — | — |
| Jul 9, 2025 | Ro Khanna |
0 | $95.16 | — | — |
| Jul 9, 2025 | Ro Khanna |
0 | $95.16 | — | — |
| Jun 16, 2025 | Ro Khanna |
0 | $92.15 | — | — |
| Jun 16, 2025 | Ro Khanna |
0 | $92.15 | — | — |
Questions
Are Zimmer Biomet insiders buying the stock?
20 open-market purchases of ZBH by Zimmer Biomet's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on February 17, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Zimmer Biomet's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.